Amanote Research
Register
Sign In
P Glycoprotein (MDR1; ABCB1; P-Gp; CD243)
Science-Business eXchange
doi 10.1038/scibx.2012.543
Full Text
Open PDF
Abstract
Available in
full text
Date
May 1, 2012
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
P Glycoprotein (ABCB1; MDR1; P-Gp)
Science-Business eXchange
Beta-Amyloid Downregulates MDR1-P-Glycoprotein (Abcb1) Expression at the Blood-Brain Barrier in Mice
International Journal of Alzheimer's Disease
Aging
Cognitive Neuroscience
Molecular Neuroscience
Neurology
Behavioral Neuroscience
Cellular
Multidrug-Resistance P-Glycoprotein (MDR1) Secretes Platelet-Activating Factor
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
In Vivo RNA Interference-Mediated Ablation of MDR1 P-Glycoprotein
Clinical Cancer Research
Cancer Research
Oncology
P-Glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer’s Disease
Oxidative Medicine and Cellular Longevity
Biochemistry
Medicine
Cell Biology
Aging
P-Gp/Abcb1 Exerts Differential Impacts on Brain and Fetal Exposure to Norbuprenorphine
Pharmacological Research
Pharmacology
Analogs of the Lignan Pinoresinol as Novel Lead Compounds for P-Glycoprotein (P-Gp) Inhibitors
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
P-Glycoprotein (P-Gp) Is Upregulated in Peripheral T-Cell Subsets From Solid Organ Transplant Recipients
Journal of Clinical Pharmacology
Pharmacology
Specific MDR1 P-Glycoprotein Blockade Inhibits Human Alloimmune T Cell Activation in Vitro
Journal of Immunology
Allergy
Immunology